C 9 H 10 N4S4, monoclinic, P21/c, a = 5.668(2) Å, b = 23.957(9) Å, c = 10.160(4) Å, β = 100.215(4)°, Z = 4, Dc = 1.480 g/cm 3 , Formula weight = 302.45, F(000) = 624, V = 1357.7(9) Å 3 ,
Formula weight = 302.45, F(000) = 624, V = 1357.7(9) Å 3 , 
Rgt(F)
=
CCDC no.: 1267/4375
Source of material 5-methyl-2-sulfanyl-1,3,4-thiadiazole (0.66 g, 5.0 mmol) was added to a stirred solution of KOH (0.28 g, 5.0 mmol) in ethanol (15 mL). The mixture was warmed to re uxed, then 1,2-dibromopropene (0.50 g, 2.5 mmol) was added dropwise and the mixture was re uxed for about 10 h. After adding additional water (20 mL), the mixture was left to stand overnight. Light yellow block crystals suitable for X-ray di raction were collected by ltration and washed with ethanol in 65% yield. 
Discussion
The rational design and synthesis of coordination architecture represents one of the most exciting and rapidly developing elds in supramolecular chemistry over the past decade, not only because of their interesting structural features but also due to their potential application as functional materials [1] [2] [3] [4] [5] 
Atom Site
coordination polymers [6, 7] . Presented herein is the crystal struture of a new thiadiazole ligand. Single crystal X-ray structural analysis reveals that the title compound crystallizes in the monoclinicspace group P21/c and the asymmetric unit of the crystal structure contains one independent C 9 H 10 N4S4 molecule. All bond lengths in the molecule are within normal ranges. The C-S lengths are in the range of 1.706(3)-1.774(3) Å, and the C4-C5 bond length is 1.312(3) Å. In the crystal, the central (C=CH) chain assumes an anti conformation.
